Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Stroke Channel:
Transient Ischemic Attack

Welcome to The Transient Ischemic Attack Channel

VJNeurology brings you the latest updates in transient ischemic attack directly from world-leading experts. The Transient Ischemic Attack Channel brings you video interviews from international conferences.

Discover key developments in this space, including updates in disease biology, novel treatment strategies, and ongoing clinical trials

The limitations of studies investigating inflammatory biomarkers after ischemic stroke or TIA 2:24
The limitations of studies investigating inflammatory biomarkers after ischemic stroke or TIA
John McCabe • 14 May 2025
The clinical relevance of perfusion-weighted MRI findings following a TIA 1:22
The clinical relevance of perfusion-weighted MRI findings following a TIA
Philipp Bücke • 21 May 2025
The evolving role of MRI in the diagnosis of TIA 1:11
The evolving role of MRI in the diagnosis of TIA
Philipp Bücke • 21 May 2025
The use of perfusion-weighted MRI to predict cerebrovascular events after TIA 1:24
The use of perfusion-weighted MRI to predict cerebrovascular events after TIA
Philipp Bücke • 21 May 2025
Enhanced benefits of the AHA Life’s Essential 8 in APOE 4 carriers 4:49
Enhanced benefits of the AHA Life’s Essential 8 in APOE 4 carriers
Santiago Clocchiatti-Tuozzo • 19 Feb 2024
Caveats of a tissue-based diagnosis of transient ischemic attack 1:52
Caveats of a tissue-based diagnosis of transient ischemic attack
Hanne Christensen • 2 Jul 2023
Diagnostic criteria for transient ischemic attacks and the challenges facing accurate diagnosis 3:55
Diagnostic criteria for transient ischemic attacks and the challenges facing accurate diagnosis
Hanne Christensen • 2 Jul 2023
The changing approach to transient ischaemic attacks management 1:03
The changing approach to transient ischaemic attacks management
Hanne Christensen • 2 Jul 2023
CHANCE-2: ticagrelor versus clopidogrel in CYP2C19 allele carriers 1:44
CHANCE-2: ticagrelor versus clopidogrel in CYP2C19 allele carriers
S. Claiborne Johnston • 7 Sep 2021
Expedited recommendation for short-term dual antiplatelet therapy after minor stroke & high-risk TIA 1:48
Expedited recommendation for short-term dual antiplatelet therapy after minor stroke & high-risk TIA
Ana Catarina Fonseca • 6 Sep 2021
Frailty and stroke 3:46
Frailty and stroke
Terence Quinn • 3 Sep 2021
Ischemic benefit vs. hemorrhagic risk in the THALES dual antiplatelet therapy trial 2:05
Ischemic benefit vs. hemorrhagic risk in the THALES dual antiplatelet therapy trial
S. Claiborne Johnston • 7 Sep 2021
The content of VJNeurology is intended for healthcare professionals